Clinical Trial

Periodontal Status and TMAO Levels in Peripheral Artery Disease

Study acronym: PAD-TMAO
Completed
View on ClinicalTrials.gov →
Summary
This observational study aims to evaluate the association between periodontal status and trimethylamine-N-oxide (TMAO) levels in patients diagnosed with peripheral artery disease (PAD). Both serum and saliva TMAO concentrations will be measured and compared according to periodontal health, periodontitis, and edentulism status. Clinical periodontal examinations and biological sample collection will be performed. The study seeks to investigate whether oral health status is associated with systemic TMAO levels in individuals with PAD.
Trial Details
NCT Number NCT07449546
Lead Sponsor Ankara University
Conditions Periodontal Diseases, Edentulism, Peripheral Arterial Disease
Enrollment 61 participants
Start Date 2022-02-15
Primary Completion 2024-01-10 (estimated)
Study Completion 2024-01-15 (estimated)
Updated on ClinicalTrials.gov 2026-03-04